Lupin Shares End 3% Higher on USFDA Nod for Schizophrenia, Bipolar Disorder Drug
Shares of Lupin Ltd ended 3% higher after hitting a day’s high of Rs 1,953.80 on 3rd September, following the company’s announcement that it has...
Tag : Lupin Ltd
Lupin Signs Deal with SteinCares for Ranibizumab Supply in Latin America; Shares Trading Flat
Shares of Lupin Ltd are trading flat after touching a day’s high of Rs 2,004.90 on 26th May, after the company announced signing an agreement...
Volumes Rise at GIC of India at Counter
On National Stock Exchange (NSE), General Insurance Corporation of India (GIC) witnessed a surge of 65.81 lakh shares over a daily average volume of 3.62...
Adani Enterprises to Replace Shree Cement in Nifty50 on NSE from Sep 30
From September 30, Adani Group‘s flagship entity, Adani Enterprises Ltd (AEL), will be included in the Nifty 50, the National Stock Exchange benchmark index, replacing...
Lupin Records Net Loss of Rs 89 Crore in Q1 FY23
Today, Lupin Ltd reported a consolidated loss of Rs 89.08 crore for the first quarter from a profit of Rs 542.46 crore last year. In...
Lupin Forays into Diagnostics Business Expected
Lupin Ltd is the pharmaceutical company that has to foray into diagnostics to leverage its ‘doctor connect to tap a sector that has low entry...
Lupin Slips 4% as Goa Plant Gets USFDA’s Observations
On Monday, Lupin Ltd’s shares dipped 4 per cent to Rs 913 on the BSE in intra-day trade after the pharmaceutical company said on Sunday...
Lupin Falls 7% Post Q1 Results
Shares of Lupin Ltd dipped 7 per cent to Rs 1,035.65, hitting an over three month low on the BSE in intra-day trade on Wednesday...
Lupin to Enter Digital Healthcare Space
Drug major Lupin Ltd has said it will enter the digital healthcare space in India with a focus to provide a digital therapeutics platform for...
Lupin Ltd Working on Partnership With Foreign Players For Covid Drugs
Lupin Ltd is working on acquiring licenses and partnerships for various Covid-19 drugs and vaccines, chief executive officer Vinita Gupta said, after the drugmaker missed...